Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 3 2

Status

Recruiting 5Unknown 2Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 217Neoplasms 175Lung Neoplasms 94Prostatic Neoplasms 89Colorectal Neoplasms 89Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Esophageal Neoplasms 24Brain Neoplasms 24Disease 23Polycystic Ovary Syndrome 22Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Leukemia, Myeloid, Acute 17Glioblastoma 17

Interventions

pyrotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × HER2-positive Breast Cancer × Clear all
NCT07198672 2025-09-30

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

Henan Cancer Hospital

Phase NA Not yet recruiting
45 enrolled
Breast

HER2-positive Breast Cancer

NCT06718335 2024-12-11

Pyrotinib in HER2-positive Early Breast Cancer

Yunnan Cancer Hospital

Phase NA Not yet recruiting
156 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡